Aktueller Kurs in CHF
Nettoinventarwert (NAV)
| 13.99 CHF | -1.02 CHF | -6.77 % |
|---|
| Vortag | 15.00 CHF | Datum | 02.11.2026 |
ETP on Saxo Cyber Security Select Equity NTR Index Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 153.36% | |
| 21Shares Stacks ETP | CH1258969042 | 135.81% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 121.23% | |
| 21Shares Arbitrum ETP | CH1304867463 | 95.16% | |
| 21shares Ethena ETP | CH1506167035 | 81.32% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 194.34% | |
| 21Shares Uniswap ETP | CH1135202096 | 127.43% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 119.46% | |
| 21Shares Injective Staking ETP | CH1360612134 | 111.47% | |
| 21Shares Raydium ETP | CH1480821391 | 102.30% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 117.27% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 88.49% | |
| 21Shares Uniswap ETP | CH1135202096 | 39.52% | |
| 21Shares Injective Staking ETP | CH1360612134 | 6.70% | |
| 21Shares Raydium ETP | CH1480821391 | 5.93% |
Fundamentaldaten
| Valor | 129209207 |
| ISIN | CH1292092074 |
| Emittent | LEONTEQ SECURITIES |
| Aufgelegt in | Switzerland |
| Auflagedatum | 30.09.2025 |
| Kategorie | Branchen: Technologie |
| Währung | CHF |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 02.11.2026 |
Anlagepolitik
So investiert der ETP on Saxo Cyber Security Select Equity NTR Index: The objective of this instrument is to provide exposure to companies delivering products and services that protect digital infrastructure and data. The selection includes businesses involved in network protection, cloud security, and identity management. The instrument seeks to reflect the long-term structural growth of the cyber security industry, driven by digitalisation and increasing regulatory focus on data protection. Returns may be affected by rapid technological change, market competition, and broader economic developments.